Comparison between Chandra Bhagat Pharma IPO and Janus IPO.
Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while Janus IPO is a SME Fixed Price proposed to list at BSE SME.
| Chandra Bhagat Pharma IPO | Janus IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Broking Ltd. | First Overseas Capital Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the Janus IPO is up to ₹7.59 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of Janus IPO is ₹50.00 per share.
| Chandra Bhagat Pharma IPO | Janus IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 19,00,000 shares | 15,18,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.69 Cr | up to ₹7.59 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,00,000 shares | 15,18,000 shares |
| Issue Size Total (Amount) | up to ₹9.69 Cr | up to ₹7.59 Cr |
Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while Janus IPO opens on Jan 27, 2020. The closing date of Chandra Bhagat Pharma IPO and Janus IPO is Feb 06, 2020, and Jan 30, 2020, respectively.
| Chandra Bhagat Pharma IPO | Janus IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 31, 2020 | Jan 27, 2020 |
| Issue Close | Feb 06, 2020 | Jan 30, 2020 |
| Basis Of Allotment (Tentative) | Feb 11, 2020 | Feb 04, 2020 |
| Initiation of Refunds (Tentative) | Feb 13, 2020 | Feb 05, 2020 |
| Credit of Share (Tentative) | Feb 13, 2020 | Feb 06, 2020 |
| Listing date (Tentative) | Feb 14, 2020 | Feb 06, 2020 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to Janus IPO P/E ratio of 57.
| Chandra Bhagat Pharma IPO | Janus IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 96.72 | 90.23 | ||||
| Promoter Shareholding (Post-Issue) | 71.08 | 65.09 | ||||
| P/E Ratio | 51 | 57 | ||||
| Market Cap | ₹38.48 Cr. | ₹28.70 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in Janus IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in Janus IPO.
| Chandra Bhagat Pharma IPO | Janus IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,00,000 shares | 81,000 shares |
| QIB | ||
| NII | 9,50,000 shares | 7,59,000 shares |
| RII | 9,50,000 shares | 7,59,000 shares |
| Employee | ||
| Others | ||
| Total | 19,00,000 shares | 15,18,000 shares |
Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas Janus IPO subscribed 1.26x.
| Chandra Bhagat Pharma IPO | Janus IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.87x | 1.03x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.44x | 1.48x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.65x | 1.26x |
